Form 4: Nuwellis Director Waller Granted Stock Options

Director Gregory D. Waller of Nuwellis, Inc. was granted 17,496 nonstatutory stock options on May 20, 2025, exercisable at $0.9558 per share.

Summary

• Gregory D. Waller, a director of Nuwellis, Inc., was granted 17,496 nonstatutory stock options on May 20, 2025.
• The options have an exercise price of $0.9558 per share.
• The options vest in 12 approximately equal monthly increments, starting one month after the grant date, and will be fully vested after one year.
• The options expire on May 19, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns director interests with shareholders.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company.

Future Outlook

The director's compensation is now tied to the company's stock performance over the next 10 years.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the director to increase shareholder value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, director, Nuwellis, Waller, equity, compensation, Form 4